Synthetic biology, “which aims to apply standardized engineering techniques to biology and thereby create organisms or biological systems with novel or specialized functions to address countless needs,”* offers the potential for tremendous benefit, alongside a range of possible risks. How should these benefits and risks be balanced, from a scientific, ethical, and policy perspective? Please join us for a discussion of these issues with a leader in the field of synthetic biology and an expert in risk regulation and policy.
- George Church, Professor of Genetics, Harvard Medical School and Director, org
- Adam Finkel, Senior Fellow and Executive Director, Penn Program on Regulation, University of Pennsylvania Law School and Clinical Professor of Environmental Health Sciences, University of Michigan School of Public Health
- Moderator: Holly Fernandez Lynch Executive Director, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
This event is free and open to the public.
A video recording will be posted after the event on our website.
Find out as soon as the video is available – subscribe to our newsletter!
Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.